companydata.dkPROXEON BIOSYSTEMS ApS: Financial statements 2025
CVR: 26848024
PROXEON BIOSYSTEMS ApS (CVR 26848024) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 2,950,000 compared with DKK 3,703,000 the year before. Equity amounted to DKK 386,590,000. The solvency ratio was 99.8%.
- Gross Profit
- 0 kr.
- Profit/Loss
- 2,950,000 kr.
- Equity
- 386,590,000 kr.
- Total Assets
- 387,551,000 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 0 | 3 mio. | 386.6 mio. | 0 |
| 2024 | - | 0 | 3.7 mio. | 383.6 mio. | - |
| 2023 | - | 36.9 mio. | -7.4 mio. | 379.9 mio. | - |
| 2022 | - | 39.4 mio. | 30.4 mio. | 387.4 mio. | - |
| 2021 | - | 30.9 mio. | 23.9 mio. | 357 mio. | - |
Find more companies like PROXEON BIOSYSTEMS ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
PROXEON BIOSYSTEMS ApS has published its annual report for 2024. Gross profit came to DKK 0, and the net result was DKK 3,703,000.
About PROXEON BIOSYSTEMS ApS
PROXEON BIOSYSTEMS ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2002. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Lie. The company is owned by NUNC A/S. The company has 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 2,950,000 compared with DKK 3,703,000 the year before. Equity amounted to DKK 386,590,000.